Engineering cancer cell membrane-camouflaged metal complex for efficient targeting therapy of breast cancer.
Engineering cancer cell membrane-camouflaged metal complex for efficient targeting therapy of breast cancer.
复制标题
DOI：
10.1186/s12951-022-01593-5
复制
发表时间：
2022-09-05
影响因子：
10.2
通讯作者：
He, Weiling
中科院分区：
文献类型：
--
作者：
Li, Xiaoying;Yu, Yanzi;Chen, Qi;Lin, Jiabao;Zhu, Xueqiong;Liu, Xiaoting;He, Lizhen;Chen, Tianfeng;He, Weiling
Cancer cell membrane-camouflaged nanotechnology for metal complex can enhance its biocompatibility and extend the effective circulation time in body. The ruthenium polypyridyl complex (RuPOP) has extensive antitumor activity, but it still has disadvantages such as poor biocompatibility, lack of targeting, and being easily metabolized by the organism. Cancer cell membranes retain a large number of surface antigens and tumor adhesion molecules CD47, which can be used to camouflage the metal complex and give it tumor homing ability and high biocompatibility. Therefore, this study provides an electrostatic adsorption method, which uses the electrostatic interaction of positive and negative charges between RuPOP and cell membranes to construct a cancer cell membrane-camouflaged nano-platform (RuPOP@CM). Interestingly, RuPOP@CM maintains the expression of surface antigens and tumor adhesion molecules, which can inhibit the phagocytosis of macrophage, reduce the clearance rate of RuPOP, and increase effective circulation time, thus enhancing the accumulation in tumor sites. Besides, RuPOP@CM can enhance the activity of cellular immune response and promote the production of inflammatory cytokines including TNF-α, IL-12 and IL-6, which is of great significance in treatment of tumor. On the other hand, RuPOP@MCM can produce intracellular ROS overproduction, thereby accelerating the apoptosis and cell cycle arrest of tumor cells to play an excellent antitumor effect in vitro and in vivo. In brief, engineering cancer cell membrane-camouflaged metal complex is a potential strategy to improve its biocompatibility, biological safety and antitumor effects. The online version contains supplementary material available at 10.1186/s12951-022-01593-5.
登录
查看更多内容
诱导癌细胞线粒体介导的细胞凋亡的钌聚吡啶复合物
影响因子：
4.6
作者：
Chen, Tianfeng;Liu, Yanan;Wong, Yum-Shing
通讯作者：
Wong, Yum-Shing
设计仿生二维 MoSe2 纳米片，通过重编程肿瘤相关巨噬细胞进行高效光热触发癌症免疫治疗
影响因子：
19
作者：
He, Lizhen;Nie, Tianqi;Chen, Tianfeng
通讯作者：
Chen, Tianfeng
影响因子：
15.7
作者：
Karges J;Stokes RW;Cohen SM
通讯作者：
Cohen SM
影响因子：
18.9
作者：
Feng, Chan;Ouyang, Jiang;Tao, Wei
通讯作者：
Tao, Wei
通过 ROS 介导的信号通路进行协同癌症化疗/放疗的双功能纳米系统
影响因子：
14
作者：
He, Lizhen;Lai, Haoqiang;Chen, Tianfeng
通讯作者：
Chen, Tianfeng